Search research articles
Contact Us
Filters
Showing results (41-50 of 94) with videos related to
Page
of 10
Sort By:
NPJ Vaccines
|
May 13, 2025
pS396/pS404 (PHF1) tau vaccine outperforms pS199/pS202 (AT8) in rTg4510 tauopathy model
Jonathan P Hulse, Nicole M Maphis, Julianne Peabody, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
|
March 12, 2014
Targeted immunomodulation using antigen-conjugated nanoparticles
Derrick P McCarthy, Zoe N Hunter, Bryce Chackerian, et al.
Antiviral Research
|
September 24, 2017
A novel candidate HPV vaccine: MS2 phage VLP displaying a tandem HPV L2 peptide offers similar protection in mice to Gardasil-9
Lukai Zhai, Julianne Peabody, Yuk-Ying Susana Pang, et al.
Vaccine
|
June 26, 2014
Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizing
Mitchell Tyler, Ebenezer Tumban, Agnieszka Dziduszko, et al.
BMC Neuroscience
|
June 10, 2004
Overcoming antigen masking of anti-amyloidbeta antibodies reveals breaking of B cell tolerance by virus-like particles in amyloidbeta immunized amyloid precursor protein transgenic mice
Qingyou Li, Chuanhai Cao, Bryce Chackerian, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
January 13, 2010
Virus-like peptide vaccines against Abeta N-terminal or C-terminal domains reduce amyloid deposition in APP transgenic mice without addition of adjuvant
Qing-you Li, Marcia N Gordon, Bryce Chackerian, et al.
Biorxiv : the Preprint Server for Biology
|
March 3, 2023
Minimal determinants for lifelong antiviral antibody responses in BALB/c mice from a single exposure to virus-like immunogens at low doses
Wei-Yun Wholey, Alexander R Meyer, Sekou-Tidiane Yoda, et al.
Vaccines
|
April 27, 2024
Minimal Determinants for Lifelong Antiviral Antibody Responses in Mice from a Single Exposure to Virus-like Immunogens at Low Doses
Wei-Yun Wholey, Alexander R Meyer, Sekou-Tidiane Yoda, et al.
Molecular Pharmaceutics
|
March 29, 2016
Optimized Formulation of a Thermostable Spray-Dried Virus-Like Particle Vaccine against Human Papillomavirus
Sugandha Saboo, Ebenezer Tumban, Julianne Peabody, et al.
Plos One
|
November 8, 2014
Development of a mimotope vaccine targeting the Staphylococcus aureus quorum sensing pathway
John P O'Rourke, Seth M Daly, Kathleen D Triplett, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 94) with videos related to
Sort By:
Page
of 10
NPJ Vaccines
|
May 13, 2025
pS396/pS404 (PHF1) tau vaccine outperforms pS199/pS202 (AT8) in rTg4510 tauopathy model
Jonathan P Hulse, Nicole M Maphis, Julianne Peabody, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
|
March 12, 2014
Targeted immunomodulation using antigen-conjugated nanoparticles
Derrick P McCarthy, Zoe N Hunter, Bryce Chackerian, et al.
Antiviral Research
|
September 24, 2017
A novel candidate HPV vaccine: MS2 phage VLP displaying a tandem HPV L2 peptide offers similar protection in mice to Gardasil-9
Lukai Zhai, Julianne Peabody, Yuk-Ying Susana Pang, et al.
Vaccine
|
June 26, 2014
Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizing
Mitchell Tyler, Ebenezer Tumban, Agnieszka Dziduszko, et al.
BMC Neuroscience
|
June 10, 2004
Overcoming antigen masking of anti-amyloidbeta antibodies reveals breaking of B cell tolerance by virus-like particles in amyloidbeta immunized amyloid precursor protein transgenic mice
Qingyou Li, Chuanhai Cao, Bryce Chackerian, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
January 13, 2010
Virus-like peptide vaccines against Abeta N-terminal or C-terminal domains reduce amyloid deposition in APP transgenic mice without addition of adjuvant
Qing-you Li, Marcia N Gordon, Bryce Chackerian, et al.
Biorxiv : the Preprint Server for Biology
|
March 3, 2023
Minimal determinants for lifelong antiviral antibody responses in BALB/c mice from a single exposure to virus-like immunogens at low doses
Wei-Yun Wholey, Alexander R Meyer, Sekou-Tidiane Yoda, et al.
Vaccines
|
April 27, 2024
Minimal Determinants for Lifelong Antiviral Antibody Responses in Mice from a Single Exposure to Virus-like Immunogens at Low Doses
Wei-Yun Wholey, Alexander R Meyer, Sekou-Tidiane Yoda, et al.
Molecular Pharmaceutics
|
March 29, 2016
Optimized Formulation of a Thermostable Spray-Dried Virus-Like Particle Vaccine against Human Papillomavirus
Sugandha Saboo, Ebenezer Tumban, Julianne Peabody, et al.
Plos One
|
November 8, 2014
Development of a mimotope vaccine targeting the Staphylococcus aureus quorum sensing pathway
John P O'Rourke, Seth M Daly, Kathleen D Triplett, et al.
Page
of 10